This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, T. Articles by Stanley, S. L. Search for Related Content PubMed PubMed Citation Articles by Zhang, T. Articles by Stanley, S. L., Jr

 Previous Article  |  Next Article 

Infect. Immun., Apr 1995, 1349-1355, Vol 63, No. 4
Copyright © 1995, American Society for Microbiology

Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response

T Zhang, E Li and SL Stanley Jr
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

The intestinal protozoan parasite Entamoeba histolytica causes amebic dysentery, a major cause of morbidity worldwide. The induction of a mucosal antibody response capable of blocking amebic adhesion to intestinal cells could represent an approach to preventing E. histolytica infection and disease. Here we describe the expression of a chimeric protein containing an immunogenic dodecapeptide derived from the serine-rich E. histolytica protein (SREHP), fused to the cholera toxin B subunit (CtxB). The CtxB-SREHP-12 chimeric protein was purified from Escherichia coli lysates and retained the critical GM1 ganglioside- binding activity of the CtxB moiety. Mice fed the CtxB-SREHP-12 fusion protein along with a subclinical dose of cholera toxin developed mucosal immunoglobulin A and immunoglobulin G and systemic antibody responses that recognized recombinant and native SREHP. Our study confirms the feasibility of inducing mucosal immune responses to immunogenic peptides by their genetic fusion to the CtxB subunit and identifies the CtxB-SREHP-12 chimeric protein as a candidate oral vaccine to prevent E. histolytica infection.

This article has been cited by other articles:

• Tsuji, N., Suzuki, K., Kasuga-Aoki, H., Matsumoto, Y., Arakawa, T., Ishiwata, K., Isobe, T. (2001). Intranasal Immunization with Recombinant Ascaris suum 14-Kilodalton Antigen Coupled with Cholera Toxin B Subunit Induces Protective Immunity to A. suum Infection in Mice. Infect. Immun. 69: 7285-7292 [Abstract] [Full Text]  
• Ryan, E. T., Crean, T. I., John, M., Butterton, J. R., Clements, J. D., Calderwood, S. B. (1999). In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 67: 1694-1701 [Abstract] [Full Text]  
• Sultan, F., Jin, L.-l., Jobling, M. G., Holmes, R. K., Stanley, S. L. Jr. (1998). Mucosal Immunogenicity of a Holotoxin-Like Molecule Containing the Serine-Rich Entamoeba histolytica Protein (SREHP) Fused to the A2 Domain of Cholera Toxin. Infect. Immun. 66: 462-468 [Abstract] [Full Text]